Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: A report from the childhood cancer survivor study

Pediatric Blood and Cancer

Volumn 60, Issue 3, 2013, Pages 461-466

  Pappo, A S ^a   Armstrong, G T ^a   Liu, W ^a   Srivastava, D K ^a   McDonald, A ^a   Leisenring, W M ^b   Hammond, S ^c   Stovall, M ^d   Neglia, J P ^e   Robison, L L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

General; Long term; Oncology; Quality of life; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEPHROBLASTOMA; NEUROBLASTOMA; OSTEOSARCOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; SURVIVORS; YOUNG ADULT;

EID: 84872432845     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24266     Document Type: Article

References (42)

1. Howlader N NA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, editors. Based on November 2010 SEER data submission, posted to the SEER web site, 2011. SEER Cancer Statistics Review, 1975-2008. http://www.seer.cancer.gov/csr/1975_2008/.
2. Mariotto AB, Rowland JH, Yabroff KR, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 1033-1040.
3. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-1582.
4. Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: The childhood cancer survivor study. J Natl Cancer Inst 2010; 102: 1083-1095.
5. Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: A report from the childhood cancer survivor study. J Clin Oncol 2005; 23: 3733-3741.
6. Braam KI, Overbeek A, Kaspers GJ, et al. Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: A systematic review. Pediatr Blood Cancer 2012; 58: 665-674.
7. Strouse JJ, Fears TR, Tucker MA, et al. Pediatric melanoma: Risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005; 23: 4735-4741.
8. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011 the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
9. Fears TR, Sagebiel RW, Halpern A, et al. Sunbeds and sunlamps: Who used them and their risk for melanoma. Pigment Cell Melanoma Res 2011; 24: 574-581.
10. Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009; 23: 383-395, vii.
11. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 2005; 23: 2272-2279.
12. Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: Long term follow-up characterises the role of DNA repair. J Med Genet 2011; 48: 168-176.
13. Pappo AS. Melanoma in children and adolescents. Eur J Cancer 2003; 39: 2651-2661.
14. Hollenbeak CS, Todd MM, Billingsley EM, et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005; 104: 1962-1967.
15. Baker KS, DeFor TE, Burns LJ, et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors. J Clin Oncol 2003; 21: 1352-1358.
16. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 2002; 38: 229-239.
17. Robison LL, Armstrong GT, Boice JD, et al. The childhood cancer survivor study: A National Cancer Institute-Supported Resource for Outcome and Intervention Research. J Clin Oncol 2009; 27: 2308-2318.
18. Leisenring WM, Mertens AC, Armstrong GT, et al. Pediatric cancer survivorship research: Experience of the childhood cancer survivor study. J Clin Oncol 2009; 27: 2319-2327.
19. Yasui Y, Liu Y, Neglia JP, et al. A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol 2003; 158: 1108-1113.
20. Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. J Am Med Assoc 2011; 305: 2311-2319.
21. Olsen JH, Moller T, Anderson H, et al. Lifelong cancer incidence in 47, 697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 2009; 101: 806-813.
22. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol 2006; 24: 476-483.
23. Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007; 12: 20-37.
24. Guerin S, Dupuy A, Anderson H, et al. Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer 2003; 39: 2379-2386.
25. Fargnoli MC, Gandini S, Peris K, et al. MC1R variants increase melanoma risk in families with CDKN2A mutations: A meta-analysis. Eur J Cancer 2010; 46: 1413-1420.
26. Royle JS, Baade P, Joske D, et al. Risk of second cancer after lymphohematopoietic neoplasm. Int J Cancer 2011; 129: 910-919.
27. Fink CA, Bates MN. Melanoma and ionizing radiation: Is there a causal relationship? Radiat Res 2005; 164: 701-710.
28. Shore R, Harley N, Pasternack B, et al. Skin cancer susceptibility among irradiated patients. J Am Acad Dermatol 1990; 22: 859-860.
29. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer J Int Cancer 2007; 121: 2233-2240.
30. Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med 1998; 338: 879-887.
31. Laver NV, McLaughlin ME, Duker JS. Ocular melanoma. Arch Pathol Lab Med 2010; 134: 1778-1784.
32. Smith CH, McGregor JM, Barker JN, et al. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993; 28: 51-55.
33. Mertens AC, Mitby PA, Radloff G, et al. XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer 2004; 101: 1463-1472.
34. Bishop DT, Demenais F, Iles MM, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009; 41: 920-925.
35. Falchi M, Bataille V, Hayward NK, et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 2009; 41: 915-919.
36. Hartley AL, Birch JM, Marsden HB, et al. Malignant melanoma in families of children with osteosarcoma, chondrosarcoma, and adrenal cortical carcinoma. J Med Genet 1987; 24: 664-668.
37. McIntyre JF, Smith-Sorensen B, Friend SH, et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994; 12: 925-930.
38. Diller L, Sexsmith E, Gottlieb A, et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 1995; 95: 1606-1611.
39. Pérot G, Chibon F, Montero A, et al. Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics. Am J Pathol 2010; 177: 2080-2090.
40. Le Mire L, Hollowood K, Gray D, et al. Melanomas in renal transplant recipients. Br J Dermatol 2006; 154: 472-477.
41. Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201-211.
42. Nathan PC, Ness KK, Mahoney MC, et al. Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: A report from the childhood cancer survivor study. Ann Intern Med 2010; 153: 442-451.